Dr. Michael Frederick Osleber, MD

Dr. Osleber practices at Arkansas Dermatology in North Little Rock, Arkansas.

Dr. Osleber's NPI, 1003013384, was assigned on June 29, 2007. Dr. Osleber graduated from University of Virginia School of Medicine in 2007. Dr. Osleber holds Arkansas license E7380.

Dr. Osleber's primary practice is Arkansas Dermatology, at 4261 Stockton Dr, North Little Rock, AR 72117 in Pulaski County. The practice phone is (501) 975-7455.

Dr. Osleber's primary practice is Arkansas Dermatology in North Little Rock, Arkansas. Dr. Osleber is also affiliated with Baptist Health Medical Center-Little Rock. The medical group on file is Arkansas Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Osleber practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Osleber's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Osleber is board certified in dermatology by the American Board of Dermatology. Dr. Osleber is licensed in Arkansas.

CMS data shows 16,502 Medicare services from Dr. Osleber across 45 procedure codes in 2024, for 1,891 Medicare patients. Medicare paid $1,120,600 for them. Every service was in an office.

CMS counts 1,891 Medicare patients who saw Dr. Osleber in 2024. The largest group is 75 to 84, with 821 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Osleber's median patient age at 77, with 43% women.

In 2024, Dr. Osleber wrote 247 Medicare Part D claims for 134 patients. 100% of them were for generic drugs. CMS names the drug for 208 of them, across 7 drugs with 11 or more claims each, at $2,816 in total drug cost. In 2023, CMS named 122 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Osleber for performance year 2024, reported individually. Dr. Osleber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 402 procedures of melanoma (skin cancer) excision by Dr. Osleber, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Osleber. Dr. Osleber's most frequent co-authors are Samantha Hope Fisher, MD and Rebecca Anne Lessner, DO.

Dmand AI links Dr. Osleber to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 203 general payments to Dr. Osleber from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $677.

Dr. Osleber graduated from University of Virginia School of Medicine in 2007.